Shanghai Pharmaceuticals Holding Co Financial Overview
Shanghai Pharmaceuticals Holding Co's market cap is currently $66.46B. The company's EPS TTM is HK$0.20986289260000002; its P/E ratio is 7.20; and it has a dividend yield of 2.67%. Shanghai Pharmaceuticals Holding Co is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is HK$0.23. See an overview of income statement, balance sheet, and cash flow financials.
